scispace - formally typeset
M

Mary Adams

Researcher at King's College London

Publications -  39
Citations -  1479

Mary Adams is an academic researcher from King's College London. The author has contributed to research in topics: Lenalidomide & Antibody-dependent cell-mediated cytotoxicity. The author has an hindex of 14, co-authored 36 publications receiving 1280 citations. Previous affiliations of Mary Adams include University of Kent & Guy's and St Thomas' NHS Foundation Trust.

Papers
More filters
Journal ArticleDOI

Interventions to increase patient and family involvement in escalation of care for acute life‐threatening illness in community health and hospital settings

TL;DR: This is a protocol for a Cochrane Review (Intervention) to assess the effects of interventions designed to increase patient and family involvement in escalation of care for acute life-threatening illness on patient andfamily outcomes, treatment outcomes, clinical outcomes, patients and family experience and adverse events.
Journal ArticleDOI

"Catching up": The significance of occupational communities for the delivery of high quality home care by community nurses

TL;DR: The findings highlight the distinctive value of informal workplace ‘catch ups’ for nurses to manage the inherent challenges of good home care for patients and to develop a shared ethic of care and professional identity and indicate the decline of ‘catching up’ between nurses.
Journal ArticleDOI

Apremilast Normalizes Gene Expression of Inflammatory Mediators in Human Keratinocytes and Reduces Antigen-Induced Atopic Dermatitis in Mice.

TL;DR: In this paper, the effects of apremilast on gene expression in adult human epidermal keratinocytes (HEKa) stimulated by Th2 and Th17 cytokines, and in two mouse models of antigen-induced AD were evaluated using immunohistochemistry and digital image analysis.
Journal ArticleDOI

Configuring the patient as clinical research subject in the UK national health service.

TL;DR: This paper examines a central image in UK academic clinical research – the patient as altruistic research subject – by means of an interpretive review of social science, bioethical and bioscience research and development policy literatures.
Journal ArticleDOI

Taking data seriously: the value of actor-network theory in rethinking patient experience data

TL;DR: It is proposed that paying attention to patient experience data as having agency in particular hospital interactions allows us to better trace how and in what circumstances data lead (or fail to lead) to quality improvement.